MIVT Expands Delivery Systems With Two New Patents

MIV Therapeutics, a developer of next-generation biocompatible coatings and drug delivery technologies, has filed two new patent applications that will enable the development and manufacture of an advanced new class of drug-eluting coatings capable of delivering multiple medicines from a cardiovascular stent or other implanted medical devices. The new patent applications expand MIVT's proprietary biocompatible coating technology platform, upon which the company is developing a line of advanced stents that are expected to offer improved therapeutic functionality and patient health.

TMCnet.com (http://www.tmcnet.com/usubmit/2005/apr/1132249.htm)